- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Second Sight Medical (NASDAQ:EYES), Quotes and News Summary
Second Sight Medical (NASDAQ: EYES)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-12 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.060 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Second Sight Medical Questions & Answers
You can purchase shares of Second Sight Medical (NASDAQ: EYES) through any online brokerage.
Other companies in Second Sight Medical’s space includes: NeuroPace (NASDAQ:NPCE), Vapotherm (NYSE:VAPO), LENSAR (NASDAQ:LNSR), Pro-Dex (NASDAQ:PDEX) and Apollo Endosurgery (NASDAQ:APEN).
The latest price target for Second Sight Medical (NASDAQ: EYES) was reported by Dougherty & Co. on Friday, December 13, 2019. The analyst firm set a price target for 2.00 expecting EYES to fall to within 12 months (a possible -8.26% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Second Sight Medical (NASDAQ: EYES) is $2.1801 last updated Today at June 27, 2022, 5:57 PM UTC.
There are no upcoming dividends for Second Sight Medical.
Second Sight Medical’s Q2 earnings are confirmed for Friday, August 12, 2022.
There is no upcoming split for Second Sight Medical.
Second Sight Medical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.